EAACI Congress 2023
BackEffect of dupilumab treatment on inflammatory type 2 biomarkers in patients with eosinophilic esophagitis: Part B of LIBERTY-EoE-TREET
Friday 09 Jun, 12:24 PM -
12:36 PM CEST
Hall Y 03+04
ORAL Session